Published Date:2024-02-29 Original Link:https://www.onenessbio.com/en/news_detail268_5.htm No 2 Date of announcement 2024/02/29 Time of announcement 16:56:20 Subject The Board of Directors resolved to distribute dividends. To which item it meets paragraph 14 Date of events 2024/02/29 Statement Date of the board of directors resolution: 2024/02/29 Year or quarter which dividends belong to: 2023 Period which dividends belong...Read More
Published Date:2024-02-29 Original Link:https://www.onenessbio.com/en/news_detail267_5.htm No 1 Date of announcement 2024/02/29 Time of announcement 16:46:11 Subject The Company’s 2023 consolidated financial statements have been approved by the Board of Directors To which item it meets paragraph 31 Date of events 2024/02/29 Statement Date of the board of directors submitted or approved: 2024/02/29 Date of the audit...Read More
Published Date:2024-02-27 Original Link:https://www.onenessbio.com/en/news_detail266_5.htm No 2 Date of announcement 2024/02/27 Time of announcement 18:40:40 Subject Oneness announces on behalf of major subsidiary Cotton Field Organic Farm Inc. about its Board of Directors resolve not to distribute dividends To which item it meets paragraph 14 Date of events 2024/02/27 Statement Date of the board of directors...Read More
Published Date:2024-02-27 Original Link:https://www.onenessbio.com/en/news_detail265_5.htm No 1 Date of announcement 2024/02/27 Time of announcement 18:40:10 Subject Oneness announces on behalf of major subsidiary Cotton Field Organic Farm Inc. about its BOD resolution to convene the 2024 Annual Shareholders’ meeting To which item it meets paragraph 17 Date of events 2024/02/27 Statement Date of the board of...Read More
Published Date:2024-02-26 Original Link:https://www.onenessbio.com/en/news_detail264_5.htm No 1 Date of announcement 2024/02/26 Time of announcement 17:17:37 Subject Oneness Biotech Co.,LTD receives a Taiwan patent on antagonistic LAG-3 aptamers. To which item it meets paragraph 53 Date of events 2024/02/26 Statement Date of occurrence of the event: 2024/02/26 Company name: ONENESS BIOTECH CO., LTD. Relationship to the Company...Read More
Published Date:2024-01-30 Original Link:https://www.onenessbio.com/en/news_detail263_5.htm No 1 Date of announcement 2024/01/30 Time of announcement 17:57:11 Subject Submission of a phase II clinical trial protocol for subcutaneous injection formulation of FB825 in patients with moderate-to-severe atopic dermatitis To which item it meets paragraph 10 Date of events 2024/01/30 Statement Product: Subcutaneous injection formulation of FB825, Anti-CεmX monoclonal...Read More
Published Date:2024-01-29 Original Link:https://www.onenessbio.com/en/news_detail262_5.htm No 1 Date of announcement 2024/01/29 Time of announcement 22:06:46 Subject Fespixon is included in the 2024 TSOC/TSPS Joint Consensus and has been published by a renowned SCI journal, Acta Cardiologica Sinica. To which item it meets paragraph 53 Date of events 2024/01/29 Statement Date of occurrence of the event: 2024/01/29...Read More
Published Date:2024-01-18 Original Link:https://www.onenessbio.com/en/news_detail261_5.htm No 1 Date of announcement 2024/01/18 Time of announcement 17:34:50 Subject Oneness was notified today that Bonvadis, the wound care topical cream has obtained import license in Thailand. To which item it meets paragraph 10 Date of events 2024/01/18 Statement Product:Bonvadis topical cream for wound care Mass production date: NA Effect...Read More
Published Date:2024-01-05 Original Link:https://www.onenessbio.com/en/news_detail260_5.htm No 1 Date of announcement 2024/01/05 Time of announcement 17:06:26 Subject Oneness Biotech to Present at the 42nd Annual J.P. Morgan Healthcare Conference To which item it meets paragraph 12 Date of events 2024/01/10 Statement Date of institutional investor conference:2024/01/10 Time of institutional investor conference:06:30 (CST) Location of institutional investor conference:San...Read More
